HD policy questions

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

3 posts / 0 new
Log in or register to post comments
Last post
Tue, 11/17/2020 - 10:39
#1
Rachel Durham
Rachel Durham's picture
Offline
Last seen: 1 month 1 week ago
Joined: 02/17/2020 - 22:00
HD policy questions

Hello all.

I posed some HD questions to ASHP's medication safety list serve and have not received a whole lot of feedback. I am going to try this group since I am at a stopping point for our HD policy roll out until I have a better grasp on how to handle one topic in particular... the handling of HDs by personnel who are pregnant or trying to conceive.

What do your policies and procedures say about handling HDs when pregnant, breastfeeding or trying to conceive? Do you have different procedures based on the level of HD or HD handling process (ie. intact anastrazole tablet handling vs compounding cyclophosphamide vs transport of prepared cyclophosphamide)? I am trying to figure out if we should or need to exempt or restrict employees from checking chemotherapy infusions (RPh), compounding chemotherapy infusions (technician), or administering HDs (nursing). I understand that this involves HR, but I just wanted to see how other facilities handle this.

Thanks in advance for your responses!

Rachel Durham PharmD RPh
Director of Pharmacy
Fulton County Health Center
Wauseon, OH 43567

Tags: 

Top